Michael B Boffa

Years Active: 2017-2024
Publications (10 Years): 5

University of Western Ontario

Queen's University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Western Ontario Jul 01 2016

Canada

Associate Professor :: Biochemistry

University of Windsor Jul 01 2014 - Jun 30 2016

Canada

Associate Professor :: Chemistry & Biochemistry

University of Windsor Jul 01 2008 - Jun 30 2014

Canada

Assistant Professor :: Chemistry & Biochemistry

Queen's University Jul 01 2004 - Jun 30 2008

Canada

Assistant Professor :: Biochemistry

Education History

Queen's University Sep 01 1994 - Jan 30 2000

Canada

PHD :: Biochemistry

Queen's University Sep 01 1991 - Aug 30 1994

Canada

MSC :: Biochemistry

Queen's University Sep 01 1987 - Aug 30 1991

Canada

BSC :: Biochemistry

Publications

Michael B Boffa, Marlys L Koschinsky
Lipoprotein(a) and cardiovascular disease. The Biochemical journal 481 (19) (2024)
Justin J W Garabon, Michael B Boffa
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme. Journal of thrombosis and thrombolysis (2023)
Amer Youssef, Justin R Clark, Santica M Marcovina, Michael B Boffa, Marlys L Koschinsky
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion. Arteriosclerosis, thrombosis, and vascular biology 42 (3) (2022)
Spencer D Christiansen, Junmin Liu, Michael B Boffa, Maria Drangova
Simultaneous R2* and quantitative susceptibility mapping measurement enables differentiation of thrombus hematocrit and age: an in vitro study at 3 T. Journal of neurointerventional surgery 11 (11) (2019)
Zainab A Bazzi, Jennifer Balun, Dora Cavallo-Medved, Lisa A Porter, Michael B Boffa
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment. Clinical & experimental metastasis 34 (2) (2017)

Michael B Boffa.css-eqlu8i{font-size:small;padding-left:4px;}